data_2lkk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.4 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.4 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' H ' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.411 ' OG ' ' O1 ' ' A' ' 129' ' ' OLA . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' OLA . . . . . 0.411 ' O1 ' ' OG ' ' A' ' 39' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.262 0.554 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -87.21 -18.44 30.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -61.67 124.43 20.68 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 121.916 2.144 . . . . 0.0 115.366 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.65 165.39 21.84 Favored Glycine 0 CA--C 1.549 2.167 0 CA-C-O 122.236 0.909 . . . . 0.0 114.801 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -106.9 87.73 2.58 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -82.4 110.9 17.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.591 -1.318 . . . . 0.0 112.907 -169.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -79.96 134.46 36.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.777 -1.202 . . . . 0.0 112.903 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.89 132.7 47.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -112.14 -63.0 1.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.86 0.864 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -119.35 138.61 52.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.77 0.795 . . . . 0.0 111.391 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -128.19 113.28 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.09 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -81.44 62.81 5.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.405 -1.434 . . . . 0.0 114.739 -175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.03 -56.94 4.19 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.199 -0.938 . . . . 0.0 111.763 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.63 -50.41 60.35 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.06 95.34 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.76 -54.49 11.52 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -40.74 91.8 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.88 -42.85 94.47 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 120.199 1.363 . . . . 0.0 113.292 168.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.89 84.6 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 pt -82.52 -5.42 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 48.78 2.78 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.94 158.06 38.86 Favored Pre-proline 0 CA--C 1.579 2.084 0 CA-C-N 118.771 1.286 . . . . 0.0 113.889 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.71 137.33 16.02 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.943 2.429 . . . . 0.0 115.842 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.33 -35.74 67.94 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.74 68.27 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 170.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.76 -36.15 77.98 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.76 -49.64 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 124.424 1.09 . . . . 0.0 111.467 174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.45 60.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -76.51 -58.54 3.22 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.073 0.851 . . . . 0.0 112.004 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.53 -7.67 69.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.913 3.125 . . . . 0.0 120.913 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.87 -41.08 87.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -106.52 -0.9 23.59 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -75.92 116.48 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.071 -1.643 . . . . 0.0 110.81 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -79.28 73.65 5.88 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-O 121.752 0.787 . . . . 0.0 112.214 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.87 176.25 47.39 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 116.123 1.209 . . . . 0.0 116.123 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.0 t -91.89 139.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.832 0.825 . . . . 0.0 110.704 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -125.69 100.35 6.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.67 149.11 25.54 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -143.33 133.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.15 106.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.1 106.46 12.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 112.572 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -114.26 66.83 0.67 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 123.233 0.613 . . . . 0.0 109.602 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.18 -97.66 0.39 Allowed Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.198 -0.939 . . . . 0.0 113.526 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.51 -34.97 19.84 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.4 113.36 23.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 120.366 1.439 . . . . 0.0 112.714 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.58 102.99 12.41 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -85.92 114.17 22.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.836 -0.54 . . . . 0.0 111.058 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -105.17 149.8 25.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -130.88 94.26 3.57 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.25 133.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.024 0.916 . . . . 0.0 112.139 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.7 p -93.29 109.62 21.15 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.764 1.269 . . . . 0.0 110.643 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.28 70.38 2.32 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-O 122.097 0.951 . . . . 0.0 109.816 172.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -93.85 0.6 Allowed Glycine 0 CA--C 1.545 1.939 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.838 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -94.43 -35.13 12.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.59 132.88 35.32 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.234 1.379 . . . . 0.0 113.824 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.4 t -92.93 107.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.71 103.38 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.97 118.01 34.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.602 1.191 . . . . 0.0 111.9 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -148.97 165.09 32.65 Favored 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 124.999 1.319 . . . . 0.0 108.481 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.17 129.67 51.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.084 -1.635 . . . . 0.0 112.912 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -101.96 133.78 46.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.452 1.12 . . . . 0.0 113.188 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -98.25 117.01 31.67 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -75.62 117.34 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.858 -1.151 . . . . 0.0 108.527 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.59 -13.51 67.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 119.099 2.4 . . . . 0.0 119.099 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -135.52 155.23 50.83 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.14 1.97 . . . . 0.0 110.925 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -50.08 132.24 23.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 118.101 2.63 . . . . 0.0 118.101 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -144.55 123.68 12.89 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.369 1.081 . . . . 0.0 112.702 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.27 117.82 23.79 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.873 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -123.66 138.67 54.49 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.58 0.752 . . . . 0.0 110.954 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.95 137.3 55.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.856 1.312 . . . . 0.0 112.856 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.12 161.78 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.699 1.238 . . . . 0.0 111.708 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.1 -59.04 3.14 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.033 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -98.62 120.57 39.28 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -115.27 1.39 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.779 0.832 . . . . 0.0 109.215 -167.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.23 112.56 1.78 Allowed 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.01 1.324 . . . . 0.0 107.899 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.0 129.28 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.78 89.51 7.18 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.472 1.13 . . . . 0.0 109.184 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -113.23 104.0 11.9 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.885 1.274 . . . . 0.0 109.761 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.43 137.3 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.703 -1.248 . . . . 0.0 110.511 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 t -106.42 131.86 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.758 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -105.21 137.44 42.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -111.51 127.68 55.78 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -114.05 128.04 56.21 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-O 122.151 0.977 . . . . 0.0 109.191 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.32 26.56 44.28 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.546 3.779 . . . . 0.0 122.546 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.338 13.3 t0 57.77 25.22 11.62 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.3 -27.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -106.14 111.22 23.75 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 120.994 1.724 . . . . 0.0 110.867 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.2 mt -106.29 119.96 40.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.622 0.769 . . . . 0.0 110.342 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.13 129.81 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.357 -0.839 . . . . 0.0 111.956 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -141.01 166.39 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.717 1.246 . . . . 0.0 113.587 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.8 102.94 10.71 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.54 -134.03 0.08 Allowed 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 123.225 0.61 . . . . 0.0 111.061 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.17 79.1 9.64 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.519 -1.988 . . . . 0.0 108.243 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.16 33.97 24.13 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.6 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 101.82 14.55 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.095 -1.003 . . . . 0.0 108.944 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.65 118.93 30.48 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.259 0.623 . . . . 0.0 111.535 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.1 109.12 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 113.99 27.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.83 134.17 54.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.806 1.184 . . . . 0.0 112.336 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.06 113.15 26.14 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.506 0.722 . . . . 0.0 109.228 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -105.18 84.97 2.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.016 -1.053 . . . . 0.0 109.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.93 -97.17 1.36 Allowed Glycine 0 N--CA 1.491 2.314 0 O-C-N 121.762 -0.587 . . . . 0.0 112.178 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -126.16 32.17 5.28 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.48 127.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.261 -1.524 . . . . 0.0 107.18 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -105.54 137.74 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 111.829 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 t -118.42 126.69 52.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.94 -0.475 . . . . 0.0 110.711 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -106.45 105.97 16.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.95 99.61 9.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.478 0.656 . . . . 0.0 110.432 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.9 mtt -90.52 102.91 15.65 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.1 0.953 . . . . 0.0 109.936 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.5 p -94.97 110.74 22.6 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.204 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.78 78.67 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.69 0.33 Allowed Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.924 -0.485 . . . . 0.0 114.171 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.93 -26.74 17.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.19 122.91 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.81 -1.181 . . . . 0.0 110.017 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -114.73 88.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.02 101.74 7.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.498 -1.376 . . . . 0.0 110.677 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.05 112.99 25.02 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -88.46 151.55 22.47 Favored 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 110.2 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.86 107.88 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 64.8 m -124.88 136.48 53.83 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.73 0.812 . . . . 0.0 111.677 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -96.69 137.38 35.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 113.203 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.94 122.94 17.25 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 CA--C 1.575 1.925 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.261 -179.675 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.748 0.785 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.2 m -75.98 118.46 18.78 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 121.665 2.029 . . . . 0.0 112.591 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.36 168.3 27.3 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.963 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.74 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.36 108.35 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.629 -1.295 . . . . 0.0 112.429 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.46 135.57 36.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.733 -1.229 . . . . 0.0 113.478 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.82 133.32 48.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.28 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.839 0.856 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.77 138.43 52.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.713 0.768 . . . . 0.0 111.446 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.83 113.74 16.32 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.46 62.89 5.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.461 -1.399 . . . . 0.0 114.733 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.18 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.227 -0.921 . . . . 0.0 111.764 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.52 -50.54 59.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.05 95.37 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 175.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.66 -54.41 12.03 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -40.77 92.07 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.86 94.53 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.122 1.328 . . . . 0.0 113.259 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.85 84.47 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.38 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.88 2.79 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 118.417 2.127 . . . . 0.0 118.417 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.08 38.87 Favored Pre-proline 0 CA--C 1.579 2.069 0 CA-C-N 118.853 1.327 . . . . 0.0 113.943 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.35 16.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.961 2.441 . . . . 0.0 115.853 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.37 -35.71 68.0 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.63 -51.72 68.36 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.87 -36.11 77.71 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.62 -49.71 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 124.462 1.105 . . . . 0.0 111.509 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.43 60.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.062 0.846 . . . . 0.0 111.988 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.41 -8.05 69.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.898 3.119 . . . . 0.0 120.898 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -66.63 -41.0 89.02 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.75 23.85 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.46 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.066 -1.646 . . . . 0.0 110.78 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.17 73.99 5.74 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.711 0.767 . . . . 0.0 112.168 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 175.2 45.34 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.33 139.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.723 0.773 . . . . 0.0 110.976 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 m -125.95 96.98 4.93 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.76 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -145.18 131.29 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.78 107.12 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.25 105.55 11.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 112.559 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -114.02 66.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 123.222 0.609 . . . . 0.0 109.867 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.34 -96.92 0.35 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 121.151 -0.968 . . . . 0.0 113.569 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.19 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.36 113.38 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.387 1.449 . . . . 0.0 112.801 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.67 102.72 12.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.25 113.48 22.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.71 150.12 25.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.36 94.03 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.02 133.64 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.086 0.946 . . . . 0.0 111.965 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.734 1.254 . . . . 0.0 110.663 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.15 70.38 2.36 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.878 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.46 0.62 Allowed Glycine 0 CA--C 1.544 1.889 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.815 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.83 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.45 132.56 35.33 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-N 120.241 1.382 . . . . 0.0 113.814 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.94 107.29 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.66 103.79 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.09 118.06 34.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.558 1.171 . . . . 0.0 111.902 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.33 164.64 34.3 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.002 1.321 . . . . 0.0 108.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.69 129.88 52.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.082 -1.636 . . . . 0.0 112.882 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.37 133.87 46.6 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.498 1.142 . . . . 0.0 113.187 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.21 116.9 31.4 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.128 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.49 117.3 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.843 -1.161 . . . . 0.0 108.564 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.67 66.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -135.42 154.87 51.31 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.071 1.936 . . . . 0.0 110.956 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 132.14 22.86 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 118.1 2.63 . . . . 0.0 118.1 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.2 13.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.382 1.087 . . . . 0.0 112.74 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.52 117.98 24.03 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.953 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -123.69 138.81 54.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.571 0.748 . . . . 0.0 110.978 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.56 55.16 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.808 1.29 . . . . 0.0 112.891 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.3 161.88 14.6 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.703 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.18 -59.11 3.08 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.976 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -98.57 120.55 39.18 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.72 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.34 -81.32 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.817 0.847 . . . . 0.0 109.258 -167.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -161.27 112.78 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.37 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.74 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.464 1.126 . . . . 0.0 109.201 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.39 103.8 11.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.954 1.302 . . . . 0.0 109.674 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.51 137.34 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.232 . . . . 0.0 110.476 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.73 132.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.816 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.15 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.494 -0.754 . . . . 0.0 109.485 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.7 tp -111.09 127.63 55.62 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.14 127.52 56.22 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 122.081 0.943 . . . . 0.0 109.224 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.53 41.21 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.568 3.787 . . . . 0.0 122.568 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 12.5 t0 58.38 25.21 12.58 Favored 'General case' 0 CA--C 1.585 2.299 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.01 -28.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.96 23.37 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 121.188 1.813 . . . . 0.0 110.887 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.14 118.48 36.66 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 0.0 110.202 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.49 129.54 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.812 . . . . 0.0 111.942 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -140.97 166.21 25.43 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.755 1.264 . . . . 0.0 113.523 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.2 m -113.63 102.96 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.79 -134.28 0.08 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.303 0.641 . . . . 0.0 111.06 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.09 79.18 9.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.475 -2.016 . . . . 0.0 108.278 174.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.03 33.85 24.0 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.18 129.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.63 101.76 14.51 Favored 'General case' 0 CA--C 1.567 1.602 0 O-C-N 121.089 -1.007 . . . . 0.0 108.891 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.83 30.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.284 0.634 . . . . 0.0 111.534 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.28 108.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.51 25.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.902 . . . . 0.0 109.419 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.89 134.63 53.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.838 1.199 . . . . 0.0 112.2 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.32 114.01 27.95 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.525 0.73 . . . . 0.0 109.483 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.01 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 109.196 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.9 1.41 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.684 -0.635 . . . . 0.0 112.258 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.22 5.66 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.227 -1.545 . . . . 0.0 107.197 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.27 136.48 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 0.0 111.707 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.7 126.92 53.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.826 -0.546 . . . . 0.0 110.83 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -106.16 106.17 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.7 m -104.93 99.57 9.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.508 0.67 . . . . 0.0 110.395 -176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.46 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.082 0.944 . . . . 0.0 109.938 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.2 p -95.0 110.63 22.52 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.195 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.73 78.68 1.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.55 -95.4 0.31 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.889 -0.507 . . . . 0.0 114.193 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.15 -26.85 17.24 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.11 122.95 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 O-C-N 120.847 -1.158 . . . . 0.0 110.086 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.5 t -114.7 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.87 7.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.537 -1.352 . . . . 0.0 110.681 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.03 112.88 24.83 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -88.56 151.16 22.68 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 110.142 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.863 0.865 . . . . 0.0 111.822 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -99.58 138.71 36.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.395 -1.441 . . . . 0.0 113.188 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.03 17.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.218 179.28 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.765 0.793 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.75 -0.94 57.8 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.4 m -76.05 118.46 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.694 2.043 . . . . 0.0 112.572 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.35 168.23 27.18 Favored Glycine 0 CA--C 1.547 2.082 0 CA-C-O 122.553 1.085 . . . . 0.0 114.991 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.63 86.7 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.611 -1.306 . . . . 0.0 112.445 -169.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -79.38 135.52 36.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.7 -1.25 . . . . 0.0 113.534 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.85 133.38 48.2 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -112.98 -63.31 1.46 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.925 0.89 . . . . 0.0 110.943 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.78 138.47 52.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 111.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.88 113.68 16.21 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.37 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.4 62.92 5.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.408 -1.432 . . . . 0.0 114.788 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.21 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 121.242 -0.911 . . . . 0.0 111.756 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.54 -50.53 59.87 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.71 -54.36 12.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.73 92.16 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.86 -42.85 94.54 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-N 120.15 1.341 . . . . 0.0 113.275 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.84 84.56 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.61 -5.28 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.85 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.15 . . . . 0.0 118.474 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.99 158.1 38.79 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.841 1.321 . . . . 0.0 113.924 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.78 137.39 15.95 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.895 2.397 . . . . 0.0 115.85 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.38 -35.67 67.99 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.75 -51.69 68.53 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.462 1.105 . . . . 0.0 113.939 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.81 -36.08 77.8 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.65 -49.71 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.412 1.085 . . . . 0.0 111.479 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.08 -26.39 60.34 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.41 3.3 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.064 0.847 . . . . 0.0 111.985 171.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 -8.1 69.99 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.53 -41.05 89.33 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.44 -0.76 23.84 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.8 mt -76.1 116.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.623 . . . . 0.0 110.774 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.23 74.11 5.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.756 0.788 . . . . 0.0 112.136 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.63 175.12 45.33 Favored Glycine 0 CA--C 1.546 2.022 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.28 139.66 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.7 0.762 . . . . 0.0 110.966 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.43 147.77 27.67 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.2 131.31 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 170.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.79 107.15 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.22 105.57 11.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 112.629 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.02 66.52 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.229 0.612 . . . . 0.0 109.821 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.37 -96.93 0.36 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.149 -0.97 . . . . 0.0 113.571 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.29 -35.2 18.59 Favored 'General case' 0 CA--C 1.573 1.851 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.399 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -87.32 113.4 23.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.392 1.451 . . . . 0.0 112.786 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.71 102.74 12.17 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.3 113.51 22.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.825 -0.547 . . . . 0.0 111.138 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.71 150.12 25.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.31 93.99 3.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.95 133.68 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 122.103 0.954 . . . . 0.0 111.965 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.19 109.49 21.0 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.659 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.21 70.37 2.34 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.125 0.964 . . . . 0.0 109.832 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 -94.52 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.76 -173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.03 -34.8 12.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.48 132.59 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.372 . . . . 0.0 113.835 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.96 107.31 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.72 103.81 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.0 34.22 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.941 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -149.34 164.7 34.16 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 125.022 1.329 . . . . 0.0 108.516 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.74 129.9 52.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.034 -1.666 . . . . 0.0 112.891 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.32 133.92 46.46 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.48 1.133 . . . . 0.0 113.198 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.2 m -98.27 116.96 31.58 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.46 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.867 -1.146 . . . . 0.0 108.535 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.67 -13.62 67.0 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.46 154.94 51.26 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.126 1.963 . . . . 0.0 110.902 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.99 132.16 22.97 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.68 124.09 13.1 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.382 1.087 . . . . 0.0 112.744 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.49 117.98 24.01 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.947 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.68 138.79 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.537 0.735 . . . . 0.0 110.924 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.0 137.56 55.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.851 1.31 . . . . 0.0 112.859 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.29 161.87 14.61 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.713 1.244 . . . . 0.0 111.697 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.1 3.1 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.02 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -98.57 120.61 39.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.65 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.38 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.796 0.838 . . . . 0.0 109.182 -167.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.28 112.82 1.79 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.96 1.304 . . . . 0.0 107.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.37 129.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.69 89.71 7.18 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.458 1.123 . . . . 0.0 109.231 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.28 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.925 1.29 . . . . 0.0 109.739 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.46 137.31 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.728 -1.233 . . . . 0.0 110.475 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.7 132.25 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.519 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.868 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.03 137.18 44.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.07 127.6 55.6 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.19 127.56 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.155 0.979 . . . . 0.0 109.184 172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.39 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 122.537 3.775 . . . . 0.0 122.537 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.44 25.06 12.48 Favored 'General case' 0 CA--C 1.585 2.292 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.64 0.47 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.23 110.96 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.207 1.821 . . . . 0.0 110.863 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.17 118.52 36.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.521 0.728 . . . . 0.0 110.224 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.58 129.55 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.439 -0.788 . . . . 0.0 111.917 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.97 166.28 25.22 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.743 1.259 . . . . 0.0 113.55 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.7 102.95 10.74 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.25 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.227 0.611 . . . . 0.0 111.104 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.12 9.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 119.533 -1.979 . . . . 0.0 108.278 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.12 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.22 129.57 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.78 14.52 Favored 'General case' 0 CA--C 1.566 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 108.878 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.42 118.8 30.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.27 0.628 . . . . 0.0 111.495 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.35 112.54 25.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 109.414 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.84 134.69 53.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.778 1.172 . . . . 0.0 112.224 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.39 114.04 28.0 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.469 0.708 . . . . 0.0 109.492 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -105.99 85.29 2.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.084 -1.01 . . . . 0.0 109.219 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.87 1.41 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.706 -0.621 . . . . 0.0 112.296 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -125.1 31.14 5.68 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.05 127.78 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.251 -1.531 . . . . 0.0 107.181 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.2 136.44 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 111.762 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.72 126.96 53.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.829 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.2 106.3 16.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.0 99.6 9.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.491 0.662 . . . . 0.0 110.385 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.51 103.03 15.76 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.089 0.947 . . . . 0.0 109.89 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.64 22.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.167 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.72 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.64 -95.54 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.937 -0.477 . . . . 0.0 114.16 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.11 -26.84 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.17 123.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.749 0 O-C-N 120.774 -1.204 . . . . 0.0 110.035 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -114.73 88.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.07 101.81 7.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.579 -1.325 . . . . 0.0 110.676 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.97 112.96 24.97 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.51 151.17 22.7 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.174 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.21 108.06 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.4 138.3 54.38 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.798 0.839 . . . . 0.0 111.782 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.61 138.74 36.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.383 -1.448 . . . . 0.0 113.192 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -62.22 122.98 16.97 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.574 1.902 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.245 179.272 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.833 0.825 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -88.69 -0.94 57.79 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 118.163 2.653 . . . . 0.0 118.163 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -76.05 118.48 18.85 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.682 2.037 . . . . 0.0 112.571 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.26 27.21 Favored Glycine 0 CA--C 1.547 2.086 0 CA-C-O 122.57 1.095 . . . . 0.0 114.993 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.69 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.36 108.31 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.643 -1.286 . . . . 0.0 112.466 -169.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.42 135.56 36.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.763 -1.21 . . . . 0.0 113.514 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.85 133.36 48.17 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.99 -63.34 1.46 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.9 0.88 . . . . 0.0 110.923 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.74 138.48 52.63 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 121.685 0.755 . . . . 0.0 111.442 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.67 16.19 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.34 -101.45 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.48 62.89 5.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.447 -1.408 . . . . 0.0 114.761 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -76.16 -56.84 4.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.921 . . . . 0.0 111.804 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.51 59.86 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -39.98 95.12 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.65 -54.5 11.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.67 91.67 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.94 -42.81 94.33 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.136 1.334 . . . . 0.0 113.27 168.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.89 84.54 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.7 pt -82.55 -5.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.02 48.79 2.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 118.436 2.134 . . . . 0.0 118.436 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.96 158.1 38.78 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 118.842 1.321 . . . . 0.0 113.876 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.81 137.46 15.97 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.909 2.406 . . . . 0.0 115.771 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.4 -35.74 68.12 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.66 -51.71 68.41 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.79 -36.06 77.81 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.68 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.443 1.097 . . . . 0.0 111.463 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.11 -26.37 60.35 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.66 -58.3 3.36 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 119.078 0.854 . . . . 0.0 112.016 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.1 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.872 3.109 . . . . 0.0 120.872 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.97 89.02 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.986 2.588 . . . . 0.0 117.986 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.45 -0.81 23.79 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.11 116.49 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.048 -1.657 . . . . 0.0 110.743 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.26 74.12 5.85 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-O 121.764 0.793 . . . . 0.0 112.135 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.65 175.17 45.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.97 97.0 4.94 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.38 147.75 27.71 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.2 mt -145.19 131.31 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.77 107.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.19 105.57 11.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 112.652 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.0 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.218 0.607 . . . . 0.0 109.882 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 -96.87 0.35 Allowed Glycine 0 N--CA 1.493 2.469 0 O-C-N 121.076 -1.015 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.17 18.61 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.413 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.36 113.38 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.411 1.46 . . . . 0.0 112.763 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.75 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.28 113.44 22.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.89 -0.506 . . . . 0.0 111.141 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.7 150.14 24.98 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 m -131.36 94.05 3.48 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.06 133.69 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 122.126 0.965 . . . . 0.0 111.951 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 p -93.1 109.45 20.93 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 122.774 1.273 . . . . 0.0 110.682 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.19 70.44 2.35 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.157 0.98 . . . . 0.0 109.852 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.05 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.786 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -94.06 -34.82 12.85 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -81.43 132.63 35.33 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.227 1.376 . . . . 0.0 113.83 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.06 107.31 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.0 mt -99.62 103.77 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.03 118.05 34.36 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.584 1.183 . . . . 0.0 111.957 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.38 164.58 34.52 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.999 1.32 . . . . 0.0 108.457 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.65 129.89 52.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.077 -1.639 . . . . 0.0 112.893 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.83 46.56 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.42 1.105 . . . . 0.0 113.19 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -98.24 116.97 31.58 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.47 117.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.864 -1.147 . . . . 0.0 108.504 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.7 -13.6 67.07 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -135.44 154.86 51.3 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.071 1.936 . . . . 0.0 110.911 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.93 132.07 22.71 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 118.126 2.639 . . . . 0.0 118.126 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.59 124.14 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.352 1.073 . . . . 0.0 112.779 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.59 118.02 24.09 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.937 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.7 138.75 54.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.566 0.746 . . . . 0.0 110.923 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.02 137.61 55.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.812 1.292 . . . . 0.0 112.873 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.36 161.84 14.65 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.677 1.227 . . . . 0.0 111.682 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.19 -59.04 3.13 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.013 171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.56 120.6 39.26 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 116.802 1.481 . . . . 0.0 116.802 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.37 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.807 0.843 . . . . 0.0 109.259 -167.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.3 112.76 1.78 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.0 1.32 . . . . 0.0 107.936 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 129.38 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.69 89.64 7.17 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.44 1.114 . . . . 0.0 109.209 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.3 103.84 11.72 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.901 1.28 . . . . 0.0 109.705 -173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.273 4.9 p -80.42 137.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.725 -1.234 . . . . 0.0 110.528 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.69 132.32 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.818 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.05 137.18 44.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.491 -0.756 . . . . 0.0 109.46 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -111.08 127.65 55.62 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.19 127.55 56.21 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.1 0.952 . . . . 0.0 109.191 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.38 27.53 40.83 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.627 3.811 . . . . 0.0 122.627 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.44 25.04 12.45 Favored 'General case' 0 CA--C 1.585 2.31 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.93 -28.62 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -106.21 110.89 23.28 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.191 1.814 . . . . 0.0 110.864 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.2 mt -105.17 118.57 36.87 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.472 0.709 . . . . 0.0 110.205 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.56 129.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.911 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.01 166.23 25.37 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 122.719 1.247 . . . . 0.0 113.527 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.6 m -113.67 102.94 10.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.8 -134.25 0.08 Allowed 'General case' 0 CA--C 1.579 2.068 0 C-N-CA 123.258 0.623 . . . . 0.0 111.104 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.13 79.17 9.61 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.459 -2.025 . . . . 0.0 108.242 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.15 33.83 23.92 Favored 'General case' 0 CA--C 1.584 2.276 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.27 129.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.48 101.69 14.43 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 108.942 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.37 118.88 30.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.234 0.614 . . . . 0.0 111.492 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.4 112.54 25.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.902 . . . . 0.0 109.414 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.64 53.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.778 1.172 . . . . 0.0 112.178 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.38 114.04 28.01 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.475 0.71 . . . . 0.0 109.493 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -106.02 85.3 2.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.07 -1.019 . . . . 0.0 109.197 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.91 1.42 Allowed Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.732 -0.605 . . . . 0.0 112.309 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.14 31.3 5.64 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.09 127.77 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.248 -1.533 . . . . 0.0 107.232 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 111.776 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.93 53.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.822 -0.548 . . . . 0.0 110.829 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.17 106.27 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.97 99.57 9.19 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.507 0.67 . . . . 0.0 110.44 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.48 103.04 15.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.043 0.925 . . . . 0.0 109.938 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.3 p -95.04 110.59 22.49 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.197 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.7 78.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.56 -95.43 0.31 Allowed Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.931 -0.481 . . . . 0.0 114.208 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.13 -26.81 17.27 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.27 123.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.809 -1.182 . . . . 0.0 110.033 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.73 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.03 101.82 7.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.541 -1.349 . . . . 0.0 110.682 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.98 112.89 24.86 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.51 151.15 22.71 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.585 -0.697 . . . . 0.0 110.178 168.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.2 107.97 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.727 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.1 m -124.35 138.25 54.39 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.82 0.848 . . . . 0.0 111.822 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.62 138.76 36.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.399 -1.438 . . . . 0.0 113.169 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 122.98 16.94 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 117.369 -1.3 . . . . 0.0 108.226 179.275 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.785 0.803 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.99 118.5 18.82 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 121.71 2.05 . . . . 0.0 112.604 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.21 27.13 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-O 122.564 1.091 . . . . 0.0 114.922 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.67 86.76 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.39 108.34 15.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.643 -1.286 . . . . 0.0 112.445 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -79.4 135.51 36.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.7 -1.25 . . . . 0.0 113.544 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.83 133.3 48.1 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.94 -63.26 1.47 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 110.99 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 138.43 52.7 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.699 0.761 . . . . 0.0 111.407 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.9 113.68 16.2 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.33 -101.49 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.44 62.85 5.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.418 -1.426 . . . . 0.0 114.775 -175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.2 -56.83 4.28 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.191 -0.943 . . . . 0.0 111.729 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.48 59.98 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.02 95.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.65 -54.45 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -40.71 91.91 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.82 94.47 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 120.175 1.352 . . . . 0.0 113.259 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.82 84.61 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.6 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.89 2.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.466 2.146 . . . . 0.0 118.466 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.0 158.06 38.92 Favored Pre-proline 0 CA--C 1.58 2.103 0 CA-C-N 118.822 1.311 . . . . 0.0 113.926 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 137.39 16.04 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.928 2.419 . . . . 0.0 115.853 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.36 -35.69 67.96 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.86 -36.08 77.69 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.66 -49.68 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 124.465 1.106 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.16 -26.36 60.46 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.62 -58.35 3.33 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.089 0.859 . . . . 0.0 112.002 171.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.39 -8.14 70.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.855 3.102 . . . . 0.0 120.855 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -41.05 89.29 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.42 -0.77 23.87 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.09 116.41 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.104 -1.622 . . . . 0.0 110.798 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.09 5.79 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-O 121.756 0.789 . . . . 0.0 112.136 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.68 175.16 45.28 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 116.163 1.225 . . . . 0.0 116.163 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.39 139.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.761 0.791 . . . . 0.0 110.898 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 m -125.97 97.01 4.94 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.39 147.72 27.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -145.14 131.28 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.78 107.11 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.61 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 112.606 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -114.04 66.56 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.174 0.589 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.9 0.35 Allowed Glycine 0 N--CA 1.493 2.457 0 O-C-N 121.12 -0.988 . . . . 0.0 113.59 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.3 -35.16 18.6 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.38 113.41 23.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.34 1.427 . . . . 0.0 112.719 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.74 102.73 12.16 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.26 113.51 22.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.854 -0.529 . . . . 0.0 111.105 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -104.73 150.09 25.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.1 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.08 133.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.142 0.972 . . . . 0.0 111.915 -171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.14 109.47 20.96 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.765 1.269 . . . . 0.0 110.689 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.13 70.42 2.37 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.097 0.951 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.08 -94.51 0.62 Allowed Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.817 -173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 m -94.04 -34.81 12.87 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.46 132.54 35.32 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.217 1.371 . . . . 0.0 113.869 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.98 107.32 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.62 103.77 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.11 34.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.525 1.155 . . . . 0.0 111.913 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -149.47 164.58 34.62 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 125.017 1.327 . . . . 0.0 108.478 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.6 129.84 52.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.034 -1.666 . . . . 0.0 112.917 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.3 133.88 46.48 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.48 1.133 . . . . 0.0 113.211 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.27 116.91 31.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.38 117.22 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.851 -1.155 . . . . 0.0 108.537 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.75 -13.64 67.02 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -135.46 154.89 51.28 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 120.098 1.949 . . . . 0.0 110.902 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.94 132.07 22.76 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.15 13.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.344 1.069 . . . . 0.0 112.722 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.48 117.96 24.0 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.963 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.67 138.77 54.47 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.578 0.751 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.02 137.57 55.17 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.846 1.308 . . . . 0.0 112.855 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.33 161.88 14.61 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.725 1.25 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.12 -59.14 3.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.001 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.52 120.55 39.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.71 -115.33 1.41 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.33 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.796 0.838 . . . . 0.0 109.245 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -161.24 112.78 1.8 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.978 1.311 . . . . 0.0 107.907 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.33 129.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.67 89.69 7.17 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.398 1.094 . . . . 0.0 109.211 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.34 103.94 11.81 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.886 1.274 . . . . 0.0 109.688 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.56 137.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.711 -1.243 . . . . 0.0 110.471 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.65 132.27 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.84 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.1 137.17 44.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.763 . . . . 0.0 109.445 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.06 127.65 55.61 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.2 127.52 56.2 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.124 0.964 . . . . 0.0 109.189 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.43 27.54 41.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 122.571 3.789 . . . . 0.0 122.571 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.332 12.5 t0 58.41 25.08 12.47 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -106.16 110.93 23.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 121.19 1.813 . . . . 0.0 110.864 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.11 118.47 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.577 0.751 . . . . 0.0 110.216 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.53 129.55 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.807 . . . . 0.0 111.935 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.94 166.28 25.21 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.768 1.27 . . . . 0.0 113.521 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.5 m -113.7 102.97 10.76 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.82 -134.21 0.08 Allowed 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 123.277 0.631 . . . . 0.0 111.124 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.08 79.13 9.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.431 -2.043 . . . . 0.0 108.262 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.1 33.8 23.89 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.24 129.62 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 101.7 14.43 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.064 -1.022 . . . . 0.0 108.922 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.35 118.81 30.13 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.275 0.63 . . . . 0.0 111.495 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.27 108.76 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.38 112.5 25.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.83 134.65 53.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.84 1.2 . . . . 0.0 112.212 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.37 114.02 27.98 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.02 85.32 2.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.96 -97.9 1.42 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.78 -0.575 . . . . 0.0 112.303 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.13 31.2 5.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.13 127.81 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.272 -1.518 . . . . 0.0 107.199 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.23 136.45 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 111.711 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.98 53.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.84 -0.537 . . . . 0.0 110.841 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -106.18 106.27 16.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -105.01 99.59 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.49 0.662 . . . . 0.0 110.421 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.52 103.06 15.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.089 0.947 . . . . 0.0 109.911 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.03 110.61 22.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.188 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.69 78.7 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.61 -95.41 0.32 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.908 -0.495 . . . . 0.0 114.206 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.18 -26.81 17.23 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.2 mm -79.21 122.98 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 110.036 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.75 88.25 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.15 101.91 7.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.327 . . . . 0.0 110.651 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.99 112.95 24.95 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -88.58 151.13 22.69 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 168.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.14 108.0 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -124.39 138.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.842 0.857 . . . . 0.0 111.778 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.71 36.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.427 -1.421 . . . . 0.0 113.247 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.16 123.06 17.15 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 117.41 -1.281 . . . . 0.0 108.214 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.749 0.785 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.83 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -75.76 118.9 19.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.732 2.06 . . . . 0.0 112.646 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.2 167.95 26.6 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 122.608 1.116 . . . . 0.0 114.928 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.37 86.67 2.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -82.04 108.28 15.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.566 -1.334 . . . . 0.0 112.489 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.82 135.66 36.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.699 -1.251 . . . . 0.0 113.455 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.56 133.48 48.59 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -113.14 -63.4 1.45 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 110.883 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.36 138.32 52.5 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.616 0.722 . . . . 0.0 111.495 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.93 114.38 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -81.98 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -81.58 63.09 5.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 114.839 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.07 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.229 -0.919 . . . . 0.0 111.728 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.55 -50.64 59.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.99 95.36 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.46 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -40.82 92.32 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -64.89 -42.74 94.54 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.101 1.319 . . . . 0.0 113.32 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.88 84.46 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.49 -5.34 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.81 48.96 2.8 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.25 158.26 38.72 Favored Pre-proline 0 CA--C 1.58 2.121 0 CA-C-N 118.838 1.319 . . . . 0.0 113.93 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.75 137.32 15.95 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.945 2.43 . . . . 0.0 115.904 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.43 -35.73 68.17 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.758 2.132 . . . . 0.0 116.758 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.63 -51.66 68.61 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.69 -36.43 78.47 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 124.468 1.107 . . . . 0.0 111.491 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.42 60.26 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.68 -58.22 3.41 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.095 0.861 . . . . 0.0 112.002 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.17 -8.61 70.29 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 120.856 3.103 . . . . 0.0 120.856 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -66.53 -40.44 89.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -106.71 -0.68 23.4 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -76.47 116.6 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.069 -1.645 . . . . 0.0 110.77 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.17 74.36 5.73 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 121.786 0.803 . . . . 0.0 112.081 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.72 45.01 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.31 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.7 0.762 . . . . 0.0 110.909 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.411 ' OG ' ' O1 ' ' A' ' 129' ' ' OLA . 37.8 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.3 147.67 27.82 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.35 132.4 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.98 107.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.2 106.41 12.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 112.691 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.83 67.26 0.69 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.708 -0.62 . . . . 0.0 109.779 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.29 -97.88 0.41 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.11 -0.994 . . . . 0.0 113.614 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.95 -34.7 19.22 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -87.91 114.25 24.35 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.316 1.416 . . . . 0.0 112.675 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -107.03 104.13 13.72 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -87.2 114.54 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.797 -0.565 . . . . 0.0 111.355 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 150.24 26.52 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 m -130.97 94.73 3.66 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.37 134.19 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.182 -0.949 . . . . 0.0 112.036 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p -93.51 110.08 21.66 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 122.774 1.273 . . . . 0.0 110.764 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.0 70.15 2.1 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 122.131 0.967 . . . . 0.0 110.009 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.36 -93.98 0.63 Allowed Glycine 0 CA--C 1.545 1.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.726 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 m -95.01 -34.65 12.26 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.08 132.49 35.37 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 120.318 1.417 . . . . 0.0 113.76 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.1 t -93.05 107.34 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -99.98 104.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.26 118.55 34.94 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.561 1.172 . . . . 0.0 112.152 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -148.7 164.09 35.37 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 124.846 1.259 . . . . 0.0 108.533 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.9 130.07 53.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.109 -1.62 . . . . 0.0 112.622 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -103.02 135.96 43.72 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.394 1.092 . . . . 0.0 113.267 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.05 116.84 33.01 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.105 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.8 t -75.76 117.22 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.848 -1.158 . . . . 0.0 108.366 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 -12.79 69.01 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -135.88 156.07 49.34 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.062 1.931 . . . . 0.0 110.941 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.09 132.78 28.02 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.68 121.41 11.89 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.272 1.034 . . . . 0.0 112.544 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.31 22.36 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.209 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -126.07 139.18 53.61 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.439 0.695 . . . . 0.0 111.108 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.47 140.87 55.73 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.218 1.485 . . . . 0.0 113.432 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.75 163.77 14.6 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.489 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 mmt -72.11 -60.08 2.41 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.735 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.5 m -97.71 120.77 38.69 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.74 -116.64 1.62 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 116.473 1.349 . . . . 0.0 116.473 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.771 0.828 . . . . 0.0 109.348 -168.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -161.42 111.77 1.67 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.002 1.321 . . . . 0.0 107.779 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.13 129.62 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.91 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.43 1.11 . . . . 0.0 109.269 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.23 104.69 12.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.89 1.276 . . . . 0.0 109.735 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.272 5.3 p -80.8 137.34 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.705 -1.247 . . . . 0.0 110.431 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 t -106.42 131.54 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 C-N-CA 123.099 0.56 . . . . 0.0 109.67 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -104.74 137.58 42.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.87 126.9 55.59 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.2 127.41 55.94 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 121.989 0.9 . . . . 0.0 109.298 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.94 27.55 37.51 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 122.57 3.788 . . . . 0.0 122.57 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.57 26.5 14.47 Favored 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.34 -29.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -105.11 110.61 23.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.363 1.892 . . . . 0.0 110.896 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.36 115.35 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.26 130.15 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.4 -0.812 . . . . 0.0 112.002 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.19 166.44 24.76 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.732 1.253 . . . . 0.0 113.688 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.1 m -113.62 102.63 10.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.251 8.8 t80 -88.95 -135.93 0.1 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 123.294 0.637 . . . . 0.0 111.413 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.07 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 119.579 -1.95 . . . . 0.0 108.421 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 56.95 32.42 21.53 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -172.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 101.96 14.69 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 108.797 174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -89.97 116.72 28.24 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.122 0.569 . . . . 0.0 111.351 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.66 107.77 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 m -105.83 110.35 22.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.55 136.63 49.38 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.415 1.007 . . . . 0.0 112.803 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.16 115.17 30.06 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.493 0.717 . . . . 0.0 109.446 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.85 84.83 2.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.004 -1.06 . . . . 0.0 109.164 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.98 -97.36 1.38 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.702 -0.624 . . . . 0.0 112.343 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.3 31.73 5.51 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.09 127.39 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.224 -1.548 . . . . 0.0 107.325 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.66 134.2 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 111.632 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.45 129.36 56.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.876 -0.515 . . . . 0.0 110.46 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.24 103.26 12.41 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.3 m -103.59 99.19 8.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.71 0.767 . . . . 0.0 110.644 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.8 mtt -91.71 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.208 1.004 . . . . 0.0 109.927 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 p -94.63 110.65 22.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.356 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.5 tp -112.5 78.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.58 -95.76 0.33 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.95 -0.469 . . . . 0.0 114.158 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.85 -26.73 17.53 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 O-C-N 120.851 -1.155 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.84 88.38 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.97 102.08 7.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.597 -1.314 . . . . 0.0 110.612 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.79 112.66 24.31 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.66 152.56 21.74 Favored 'General case' 0 CA--C 1.57 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.175 168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.73 107.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.8 m -124.28 136.38 54.09 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.793 0.837 . . . . 0.0 111.792 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -98.02 138.5 35.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.47 -1.394 . . . . 0.0 113.366 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -61.92 122.91 16.62 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.8 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.413 -1.28 . . . . 0.0 108.282 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . 0.411 ' O1 ' ' OG ' ' A' ' 39' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.791 0.805 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.66 -1.07 57.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.5 m -75.93 118.52 18.8 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 121.656 2.026 . . . . 0.0 112.602 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.3 168.28 27.21 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-O 122.515 1.064 . . . . 0.0 114.947 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -107.71 86.74 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.37 108.29 15.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.59 -1.319 . . . . 0.0 112.433 -169.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.39 135.5 36.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.744 -1.222 . . . . 0.0 113.505 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.8 133.4 48.26 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -113.04 -63.33 1.46 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.878 0.871 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.72 138.46 52.64 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.701 0.762 . . . . 0.0 111.434 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.89 113.71 16.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.43 -101.44 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -171.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.91 5.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.409 -1.432 . . . . 0.0 114.764 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -76.24 -56.87 4.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.194 -0.941 . . . . 0.0 111.726 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.5 -50.59 59.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.0 95.27 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -70.61 -54.5 11.76 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.68 91.68 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.96 -42.81 94.27 Favored 'General case' 0 CA--C 1.574 1.893 0 CA-C-N 120.132 1.333 . . . . 0.0 113.209 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -38.85 84.41 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 pt -82.63 -5.32 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 48.84 2.8 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -112.93 158.08 38.8 Favored Pre-proline 0 CA--C 1.58 2.113 0 CA-C-N 118.792 1.296 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.76 137.4 16.0 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.895 2.397 . . . . 0.0 115.848 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.33 -35.76 67.96 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.61 -51.74 68.26 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 mt -68.8 -36.11 77.84 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.63 -49.71 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 C-N-CA 124.475 1.11 . . . . 0.0 111.502 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.43 60.4 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.6 -58.39 3.31 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 119.042 0.837 . . . . 0.0 111.958 171.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 -8.05 70.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 120.844 3.098 . . . . 0.0 120.844 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.58 -41.0 89.19 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.47 -0.73 23.82 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.7 mt -76.15 116.4 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.135 -1.603 . . . . 0.0 110.774 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.14 74.09 5.71 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 121.75 0.786 . . . . 0.0 112.176 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 175.17 45.22 Favored Glycine 0 CA--C 1.546 2.01 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.35 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.67 0.748 . . . . 0.0 110.946 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -126.01 97.02 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.42 147.81 27.65 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.3 mt -145.24 131.27 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.72 107.09 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.21 105.54 11.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 112.637 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -114.05 66.56 0.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.184 0.594 . . . . 0.0 109.854 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.89 0.35 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.089 -1.007 . . . . 0.0 113.563 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.35 -35.15 18.55 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 118.221 -0.895 . . . . 0.0 113.404 171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -87.35 113.4 23.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 120.416 1.462 . . . . 0.0 112.76 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -105.77 102.76 12.19 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -86.24 113.44 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.852 -0.53 . . . . 0.0 111.158 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.252 0.1 OUTLIER -104.69 150.17 24.95 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -178.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.35 94.01 3.47 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.99 133.69 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 122.096 0.951 . . . . 0.0 111.975 -171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p -93.21 109.51 21.02 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.751 1.263 . . . . 0.0 110.617 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.17 70.4 2.36 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 122.106 0.955 . . . . 0.0 109.828 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.06 -94.54 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.772 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 m -93.95 -34.87 12.91 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.42 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 120.179 1.354 . . . . 0.0 113.856 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -93.02 107.26 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.768 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -99.69 103.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.12 118.06 34.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.578 1.18 . . . . 0.0 111.937 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -149.37 164.57 34.54 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.009 1.324 . . . . 0.0 108.5 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.66 129.85 52.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.095 -1.628 . . . . 0.0 112.929 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -102.29 133.89 46.46 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.457 1.122 . . . . 0.0 113.19 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.28 116.93 31.55 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.47 117.34 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.914 -1.116 . . . . 0.0 108.489 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.66 66.89 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -135.36 154.93 51.33 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.137 1.968 . . . . 0.0 110.953 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.01 132.15 23.04 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 118.073 2.62 . . . . 0.0 118.073 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.0 p -144.66 124.14 13.16 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.36 1.076 . . . . 0.0 112.789 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.54 118.03 24.07 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.947 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.69 138.83 54.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.593 0.757 . . . . 0.0 110.94 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -68.02 137.55 55.16 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.825 1.298 . . . . 0.0 112.882 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 t -108.29 161.84 14.63 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.795 1.238 . . . . 0.0 111.746 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 mmt -70.21 -59.06 3.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.021 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.5 m -98.52 120.62 39.25 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.63 -115.28 1.4 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -81.37 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.837 0.855 . . . . 0.0 109.24 -167.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.27 112.76 1.79 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.006 1.322 . . . . 0.0 107.903 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 129.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.73 7.18 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.469 1.128 . . . . 0.0 109.206 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.37 103.79 11.65 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.955 1.302 . . . . 0.0 109.727 -173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -80.45 137.31 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.721 -1.237 . . . . 0.0 110.535 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.67 132.28 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.84 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.07 137.17 44.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.465 -0.772 . . . . 0.0 109.448 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.07 127.58 55.6 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.13 127.56 56.23 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 122.141 0.972 . . . . 0.0 109.228 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.53 40.86 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.592 3.797 . . . . 0.0 122.592 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.5 t0 58.45 25.11 12.57 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.96 -28.78 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -106.13 110.88 23.28 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 121.222 1.828 . . . . 0.0 110.89 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.3 mt -105.08 118.45 36.57 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.543 0.737 . . . . 0.0 110.207 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.48 129.59 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.799 . . . . 0.0 111.962 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.27 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.759 1.266 . . . . 0.0 113.538 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 m -113.71 102.97 10.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -87.77 -134.26 0.08 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.096 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.1 79.13 9.62 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.472 -2.018 . . . . 0.0 108.276 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 57.11 33.82 23.92 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -172.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.22 129.62 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 101.73 14.47 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.067 -1.02 . . . . 0.0 108.881 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -90.39 118.83 30.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.301 0.641 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.2 t -117.29 108.74 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.49 25.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.38 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.81 134.65 53.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.773 1.17 . . . . 0.0 112.209 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.36 114.05 28.02 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.494 0.718 . . . . 0.0 109.486 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -106.04 85.37 2.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.142 -0.974 . . . . 0.0 109.151 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.87 -97.89 1.4 Allowed Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.727 -0.608 . . . . 0.0 112.316 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -125.1 31.17 5.67 Favored 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.01 127.76 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.215 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.14 136.48 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 111.775 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.78 126.86 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.826 -0.546 . . . . 0.0 110.841 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.09 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.6 m -104.96 99.59 9.21 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.429 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.4 mtt -90.47 103.0 15.74 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.086 0.946 . . . . 0.0 109.958 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.1 p -95.06 110.63 22.53 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.21 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.7 78.72 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.63 -95.51 0.32 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.88 -0.512 . . . . 0.0 114.178 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.12 -26.8 17.28 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.3 mm -79.15 122.96 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 O-C-N 120.801 -1.187 . . . . 0.0 110.072 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.72 88.21 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -78.1 101.82 7.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.623 -1.298 . . . . 0.0 110.702 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -111.94 112.87 24.83 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.48 151.12 22.75 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.605 -0.685 . . . . 0.0 110.186 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.15 108.01 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -124.4 138.21 54.38 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.824 0.849 . . . . 0.0 111.786 -176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.57 138.75 36.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.412 -1.43 . . . . 0.0 113.179 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.19 123.01 17.03 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.575 1.914 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.158 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.811 0.815 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -88.73 -0.98 57.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 m -75.91 118.45 18.71 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 121.683 2.038 . . . . 0.0 112.59 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.34 168.27 27.25 Favored Glycine 0 CA--C 1.548 2.115 0 CA-C-O 122.515 1.064 . . . . 0.0 114.978 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.71 86.78 2.36 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -82.38 108.37 15.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.558 -1.339 . . . . 0.0 112.403 -169.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -79.46 135.53 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.715 -1.241 . . . . 0.0 113.52 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -68.89 133.37 48.15 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.91 0.884 . . . . 0.0 110.926 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -118.79 138.49 52.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.737 0.78 . . . . 0.0 111.412 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -127.92 113.73 16.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -81.41 -101.47 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.43 62.87 5.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.427 -1.42 . . . . 0.0 114.764 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.24 -56.84 4.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.247 -0.908 . . . . 0.0 111.738 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.5 -50.53 59.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.96 95.14 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -70.7 -54.44 11.81 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -40.7 91.75 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.93 -42.78 94.39 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.178 1.353 . . . . 0.0 113.254 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -38.81 84.58 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.63 -5.27 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.88 48.88 2.81 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.01 158.07 38.9 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-N 118.797 1.298 . . . . 0.0 113.875 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.7 137.34 16.05 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.952 2.435 . . . . 0.0 115.874 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -56.36 -35.72 67.99 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -57.6 -51.76 68.19 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -68.8 -36.09 77.83 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -61.7 -49.71 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 124.475 1.11 . . . . 0.0 111.439 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.09 -26.39 60.35 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.65 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 119.048 0.84 . . . . 0.0 111.976 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 -8.01 70.03 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 120.862 3.105 . . . . 0.0 120.862 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.62 -40.96 89.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.94 2.571 . . . . 0.0 117.94 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.54 -0.7 23.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -76.15 116.48 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.048 -1.657 . . . . 0.0 110.754 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -79.21 74.06 5.79 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-O 121.721 0.772 . . . . 0.0 112.152 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.17 45.35 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 116.192 1.237 . . . . 0.0 116.192 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.35 139.64 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.705 0.764 . . . . 0.0 110.973 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -125.93 97.03 4.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mt -145.24 131.21 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 171.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -114.73 107.1 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -80.13 105.52 11.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 112.685 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -113.97 66.5 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.215 0.606 . . . . 0.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.36 -96.93 0.36 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.098 -1.001 . . . . 0.0 113.566 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.28 -35.21 18.6 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -87.32 113.41 23.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.372 1.442 . . . . 0.0 112.785 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.7 102.63 12.07 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -86.2 113.48 22.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.836 -0.54 . . . . 0.0 111.125 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -104.74 150.08 25.06 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 m -131.27 94.05 3.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.69 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.11 0.957 . . . . 0.0 111.963 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.16 109.53 21.03 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.764 1.269 . . . . 0.0 110.681 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.23 70.48 2.34 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.134 0.968 . . . . 0.0 109.849 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.1 -94.48 0.62 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.786 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -94.08 -34.83 12.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -81.44 132.58 35.33 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 120.173 1.352 . . . . 0.0 113.873 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -93.0 107.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.782 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -99.65 103.76 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.02 118.07 34.42 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.56 1.171 . . . . 0.0 111.957 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -149.39 164.58 34.56 Favored 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 124.968 1.307 . . . . 0.0 108.453 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -122.63 129.88 52.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.059 -1.651 . . . . 0.0 112.886 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -102.31 133.89 46.48 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.432 1.11 . . . . 0.0 113.177 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 116.9 31.45 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.43 117.28 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.867 -1.145 . . . . 0.0 108.567 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.66 -13.62 67.0 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -135.41 154.97 51.28 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.118 1.959 . . . . 0.0 110.944 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.04 132.15 23.21 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.1 p -144.62 124.16 13.21 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.328 1.061 . . . . 0.0 112.754 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.51 117.99 24.04 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.972 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -123.73 138.74 54.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.583 0.753 . . . . 0.0 110.912 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.91 137.53 55.3 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.848 1.308 . . . . 0.0 112.913 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -108.35 161.83 14.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.722 1.248 . . . . 0.0 111.697 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.6 mmt -70.14 -59.05 3.13 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.046 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -98.61 120.57 39.27 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.68 -115.27 1.4 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -81.29 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.798 0.839 . . . . 0.0 109.18 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -161.31 112.79 1.78 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.0 1.32 . . . . 0.0 107.869 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.34 129.38 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -83.66 89.83 7.19 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.479 1.133 . . . . 0.0 109.206 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -113.48 103.83 11.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.915 1.286 . . . . 0.0 109.643 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.0 p -80.52 137.36 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.712 -1.243 . . . . 0.0 110.521 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.68 132.27 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.799 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.08 137.22 44.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.473 -0.767 . . . . 0.0 109.431 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -111.14 127.63 55.64 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -113.16 127.5 56.21 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 122.123 0.963 . . . . 0.0 109.193 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.45 27.54 41.32 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.331 12.6 t0 58.38 25.19 12.55 Favored 'General case' 0 CA--C 1.585 2.312 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -144.99 -28.72 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -106.1 110.93 23.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 121.204 1.82 . . . . 0.0 110.91 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.12 118.41 36.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.605 0.762 . . . . 0.0 110.224 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.48 129.58 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.427 -0.796 . . . . 0.0 111.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -140.99 166.27 25.26 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.755 1.264 . . . . 0.0 113.512 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 m -113.74 103.01 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -87.84 -134.21 0.08 Allowed 'General case' 0 CA--C 1.579 2.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.105 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -84.1 79.19 9.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 119.487 -2.008 . . . . 0.0 108.276 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 57.05 33.87 24.02 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -133.25 129.68 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.58 101.79 14.53 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 108.869 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -90.42 118.87 30.24 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.247 0.619 . . . . 0.0 111.483 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.33 108.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 m -102.36 112.47 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -111.86 134.71 53.25 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.83 1.195 . . . . 0.0 112.186 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.35 114.01 27.95 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 123.455 0.702 . . . . 0.0 109.521 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -105.95 85.28 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.186 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.92 -97.83 1.41 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.686 -0.634 . . . . 0.0 112.278 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -125.19 31.23 5.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.02 127.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.243 -1.536 . . . . 0.0 107.248 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -106.18 136.47 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 111.739 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -117.74 126.83 53.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.87 -0.519 . . . . 0.0 110.845 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -106.11 106.24 16.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.5 m -104.93 99.54 9.16 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.519 0.676 . . . . 0.0 110.421 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 mtt -90.47 103.04 15.78 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.072 0.939 . . . . 0.0 109.906 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 p -95.05 110.67 22.57 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.16 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.3 tp -112.75 78.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.57 -95.46 0.32 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.928 -0.482 . . . . 0.0 114.162 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.09 -26.87 17.27 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mm -79.18 122.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 120.849 -1.157 . . . . 0.0 110.029 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.68 88.24 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -78.09 101.86 7.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.579 -1.326 . . . . 0.0 110.678 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -112.01 112.91 24.88 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -88.52 151.12 22.73 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 121.625 -0.672 . . . . 0.0 110.18 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.16 108.03 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.9 m -124.38 138.18 54.39 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.82 0.848 . . . . 0.0 111.795 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -99.54 138.73 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.38 -1.45 . . . . 0.0 113.174 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -62.2 123.07 17.18 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.574 1.882 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.244 179.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.77 0.795 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -88.79 -1.4 58.07 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 m -75.71 118.89 19.02 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 121.732 2.06 . . . . 0.0 112.661 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.21 167.93 26.57 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-O 122.526 1.07 . . . . 0.0 114.954 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -107.36 86.65 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -82.04 108.27 15.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 112.493 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -79.77 135.59 36.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.72 -1.238 . . . . 0.0 113.444 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.51 133.41 48.54 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -113.13 -63.36 1.46 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.906 0.882 . . . . 0.0 110.877 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -118.38 138.37 52.48 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.643 0.735 . . . . 0.0 111.514 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -127.95 114.38 17.07 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -81.93 -101.79 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -81.59 63.13 5.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.374 -1.454 . . . . 0.0 114.808 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -76.14 -56.93 4.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.214 -0.929 . . . . 0.0 111.743 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.2 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -70.44 -54.33 12.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -40.79 92.42 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.81 -42.84 94.68 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 120.124 1.329 . . . . 0.0 113.276 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.84 84.59 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.4 -5.5 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.97 48.9 2.78 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.24 158.23 38.79 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-N 118.871 1.335 . . . . 0.0 113.975 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -77.69 137.35 16.07 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.94 2.427 . . . . 0.0 115.908 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -56.41 -35.75 68.14 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.67 -51.65 68.67 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.2 mt -68.66 -36.47 78.6 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.1 mt -61.47 -49.6 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.49 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.0 -26.53 60.4 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.57 -58.26 3.38 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 119.023 0.829 . . . . 0.0 112.013 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.16 -8.66 70.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 120.864 3.106 . . . . 0.0 120.864 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.54 -40.41 89.09 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -106.69 -0.75 23.39 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -76.48 116.52 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.045 -1.66 . . . . 0.0 110.737 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -79.03 74.39 5.56 Favored 'General case' 0 CA--C 1.573 1.847 0 CA-C-O 121.704 0.764 . . . . 0.0 112.064 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.63 44.93 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.38 139.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.751 0.786 . . . . 0.0 110.918 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 m -125.9 96.62 4.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.34 147.64 27.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.1 mt -145.37 132.43 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 171.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 t -116.01 107.01 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -80.1 106.33 12.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 112.702 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -114.8 67.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.191 0.596 . . . . 0.0 109.788 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.3 -97.83 0.41 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.126 -0.984 . . . . 0.0 113.624 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.06 -34.6 19.12 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -87.99 114.28 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.334 1.425 . . . . 0.0 112.609 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -107.06 104.22 13.82 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -87.28 114.6 24.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.855 -0.528 . . . . 0.0 111.32 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.82 150.27 26.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -130.94 94.74 3.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.39 134.19 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 122.079 0.942 . . . . 0.0 112.024 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 p -93.58 110.05 21.65 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.859 1.314 . . . . 0.0 110.745 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 70.11 2.09 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 122.14 0.971 . . . . 0.0 110.037 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.97 0.63 Allowed Glycine 0 CA--C 1.545 1.926 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.74 -173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -94.97 -34.77 12.24 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -81.02 132.52 35.37 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 120.251 1.387 . . . . 0.0 113.803 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.07 107.36 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.01 104.89 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.29 118.53 34.88 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.523 1.154 . . . . 0.0 112.152 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -148.72 164.12 35.32 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.895 1.278 . . . . 0.0 108.533 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.89 130.03 53.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.196 -1.565 . . . . 0.0 112.616 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -102.99 135.96 43.7 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 122.31 1.052 . . . . 0.0 113.313 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 m -100.01 116.86 33.04 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.76 117.16 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.9 -1.125 . . . . 0.0 108.345 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -12.83 68.97 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -135.91 156.05 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.062 1.931 . . . . 0.0 110.963 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.08 132.71 27.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -143.63 121.49 11.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.286 1.041 . . . . 0.0 112.454 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.41 117.21 22.29 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.235 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 mt -126.06 139.15 53.63 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.367 0.667 . . . . 0.0 111.055 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -68.46 140.77 55.75 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 123.275 1.512 . . . . 0.0 113.464 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 t -113.59 163.82 14.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.486 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 mmt -72.21 -59.99 2.46 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.755 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 m -97.72 120.78 38.73 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 170.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.68 1.63 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.64 -81.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.812 0.845 . . . . 0.0 109.319 -168.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -161.41 111.75 1.67 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.953 1.301 . . . . 0.0 107.733 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.19 129.7 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.64 88.87 7.05 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.48 1.133 . . . . 0.0 109.269 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.18 104.72 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.877 1.271 . . . . 0.0 109.735 -173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.27 5.3 p -80.91 137.4 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.79 -1.194 . . . . 0.0 110.45 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.45 131.51 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.741 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -104.68 137.63 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.507 -0.745 . . . . 0.0 109.464 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.88 126.86 55.56 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.1 127.45 55.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.932 0.872 . . . . 0.0 109.291 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.76 27.64 36.38 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 122.573 3.789 . . . . 0.0 122.573 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.335 12.6 t0 58.59 26.58 14.6 Favored 'General case' 0 CA--C 1.585 2.296 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.35 -29.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -105.06 110.54 22.98 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 121.424 1.92 . . . . 0.0 110.898 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.3 mt -104.26 115.26 30.08 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.528 0.731 . . . . 0.0 110.051 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.22 130.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 111.978 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -141.2 166.43 24.79 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.784 1.278 . . . . 0.0 113.698 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.8 m -113.58 102.6 10.43 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.6 t80 -88.87 -135.88 0.1 Allowed 'General case' 0 CA--C 1.579 2.095 0 C-N-CA 123.336 0.654 . . . . 0.0 111.425 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -83.08 79.1 9.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.628 -1.92 . . . . 0.0 108.378 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 56.92 32.48 21.6 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -172.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.52 128.97 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 101.97 14.71 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 108.825 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -90.0 116.66 28.22 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.5 t -114.56 107.71 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -105.81 110.23 22.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -110.44 136.71 49.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.418 1.008 . . . . 0.0 112.805 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.17 115.17 30.07 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.556 0.743 . . . . 0.0 109.452 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -106.87 84.79 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.973 -1.079 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.94 -97.37 1.37 Allowed Glycine 0 N--CA 1.492 2.39 0 O-C-N 121.691 -0.63 . . . . 0.0 112.331 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -125.25 31.73 5.52 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.16 127.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.23 -1.544 . . . . 0.0 107.278 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 tt -105.69 134.25 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 111.613 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -113.56 129.14 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.827 -0.545 . . . . 0.0 110.478 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -107.99 103.25 12.44 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.1 m -103.65 99.16 8.95 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.748 0.785 . . . . 0.0 110.692 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.9 mtt -91.67 102.36 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.22 1.01 . . . . 0.0 109.995 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -94.64 110.78 22.58 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.4 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 tp -112.76 78.66 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.98 0.34 Allowed Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.919 -0.488 . . . . 0.0 114.161 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.76 -26.63 17.64 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.07 123.06 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.716 0 O-C-N 120.809 -1.182 . . . . 0.0 110.02 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.7 t -114.86 88.36 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -77.93 102.08 7.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.521 -1.362 . . . . 0.0 110.604 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.85 112.6 24.19 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -88.6 152.57 21.75 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.55 0.69 . . . . 0.0 110.168 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.67 107.89 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m -124.23 136.35 54.09 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.798 0.839 . . . . 0.0 111.796 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -98.08 138.53 35.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.475 -1.391 . . . . 0.0 113.348 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -61.95 122.85 16.49 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.251 28.5 mt . . . . . 0 CA--C 1.574 1.894 0 CA-C-O 117.445 -1.264 . . . . 0.0 108.27 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.237 0.541 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -87.63 -18.5 29.47 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -61.74 125.24 23.13 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 121.913 2.142 . . . . 0.0 115.356 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.18 165.24 21.07 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 122.268 0.927 . . . . 0.0 114.733 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.54 87.6 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -82.06 110.64 17.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.676 -1.265 . . . . 0.0 112.98 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -80.26 134.68 36.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.814 -1.179 . . . . 0.0 112.906 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.67 132.86 47.57 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -112.31 -63.05 1.48 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.837 0.855 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -118.94 138.46 52.77 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.708 0.766 . . . . 0.0 111.51 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -128.22 113.8 16.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -81.59 -101.6 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -81.64 62.97 5.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.388 -1.445 . . . . 0.0 114.749 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -75.95 -56.97 4.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 111.766 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.53 -50.64 59.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.03 95.46 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.64 -54.35 12.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -40.88 92.44 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -64.87 -42.84 94.52 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.152 1.342 . . . . 0.0 113.256 168.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.89 84.37 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 pt -82.45 -5.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.95 48.85 2.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.19 158.23 38.7 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 118.869 1.334 . . . . 0.0 113.953 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.75 137.5 16.11 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.948 2.432 . . . . 0.0 115.825 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.55 -35.69 68.43 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.61 -51.68 68.53 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -68.63 -36.5 78.71 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -61.57 -49.56 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 C-N-CA 124.414 1.086 . . . . 0.0 111.497 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -57.02 -26.47 60.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -76.55 -58.38 3.31 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.049 0.84 . . . . 0.0 112.007 172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.21 69.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -66.79 -40.52 88.15 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -106.8 -0.87 23.09 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.5 mt -76.23 116.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.048 -1.658 . . . . 0.0 110.812 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -79.14 73.93 5.71 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.736 0.779 . . . . 0.0 112.148 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 175.7 46.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 116.181 1.233 . . . . 0.0 116.181 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -91.66 139.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.87 0.843 . . . . 0.0 110.722 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 m -125.93 99.89 6.14 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.5 149.1 25.62 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -143.49 134.55 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -119.48 106.04 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -79.94 107.52 12.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 112.572 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -115.32 67.49 0.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.266 0.626 . . . . 0.0 109.588 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.17 -98.5 0.44 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.157 -0.964 . . . . 0.0 113.597 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -86.36 -34.62 20.18 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 171.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -88.0 114.32 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.321 1.419 . . . . 0.0 112.58 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.0 104.67 14.4 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -86.93 115.39 24.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.809 -0.557 . . . . 0.0 111.225 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.46 150.0 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -130.53 95.18 3.81 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mm -104.88 133.94 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.164 -0.96 . . . . 0.0 112.223 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 p -93.57 110.03 21.63 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.825 1.298 . . . . 0.0 110.681 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.99 70.08 2.09 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.121 0.963 . . . . 0.0 109.956 172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.55 -93.33 0.62 Allowed Glycine 0 CA--C 1.545 1.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.758 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.1 m -95.48 -35.06 11.84 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -81.16 132.79 35.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.262 1.392 . . . . 0.0 113.794 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -92.96 107.38 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.02 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.06 118.52 35.01 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 122.52 1.153 . . . . 0.0 112.099 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -148.41 164.35 34.38 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.883 1.273 . . . . 0.0 108.6 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -122.18 129.7 52.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.219 -1.551 . . . . 0.0 112.614 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -102.61 135.98 43.26 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.389 1.09 . . . . 0.0 113.267 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -99.99 117.05 33.44 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.115 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.11 117.44 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 108.316 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.32 -12.5 69.5 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 119.076 2.39 . . . . 0.0 119.076 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -136.01 156.87 48.09 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.059 1.929 . . . . 0.0 111.002 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -51.52 132.91 30.38 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.7 p -143.72 121.22 11.72 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.254 1.026 . . . . 0.0 112.457 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.18 116.96 21.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.187 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 mt -125.76 138.78 53.87 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.442 0.697 . . . . 0.0 111.025 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.33 140.75 55.93 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.236 1.493 . . . . 0.0 113.425 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -113.78 163.83 14.53 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.461 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.4 mmt -72.14 -60.19 2.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.688 172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.9 m -97.67 120.75 38.61 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.73 -116.65 1.63 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 116.418 1.327 . . . . 0.0 116.418 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.7 -81.01 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.764 0.825 . . . . 0.0 109.378 -168.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -161.52 111.69 1.64 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.969 1.308 . . . . 0.0 107.724 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.9 129.47 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -83.62 88.83 7.05 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.452 1.12 . . . . 0.0 109.254 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -113.22 105.11 13.03 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.864 1.266 . . . . 0.0 109.765 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.268 5.8 p -80.95 137.23 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.713 -1.242 . . . . 0.0 110.399 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.01 130.93 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.602 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -103.63 137.83 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.597 -0.69 . . . . 0.0 109.444 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.31 126.73 55.57 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.39 128.09 56.34 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-O 122.158 0.98 . . . . 0.0 109.201 172.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.16 26.71 43.74 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 122.483 3.753 . . . . 0.0 122.483 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t0 57.77 25.93 12.49 Favored 'General case' 0 CA--C 1.586 2.345 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -145.42 -27.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -105.35 110.38 22.71 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 121.138 1.79 . . . . 0.0 110.879 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.3 116.05 31.29 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.629 0.772 . . . . 0.0 110.24 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.26 130.41 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.377 -0.827 . . . . 0.0 112.04 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 t -141.35 166.74 23.93 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.791 1.281 . . . . 0.0 113.729 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.7 m -113.96 102.53 10.28 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.25 8.4 t80 -88.54 -135.5 0.1 Allowed 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 123.304 0.642 . . . . 0.0 111.401 -174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -83.04 78.96 9.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.561 -1.962 . . . . 0.0 108.434 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m120 57.0 32.66 22.05 Favored 'General case' 0 CA--C 1.584 2.267 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 mt -132.5 128.88 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 102.02 14.74 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.857 174.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 t -90.18 116.37 28.13 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.155 0.582 . . . . 0.0 111.374 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.76 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -107.69 111.08 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.566 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.34 136.47 51.76 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.378 0.99 . . . . 0.0 112.94 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.05 113.74 27.24 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.509 0.723 . . . . 0.0 109.156 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.24 84.71 2.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 109.28 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.95 -96.5 1.32 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 121.774 -0.579 . . . . 0.0 112.205 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -126.53 32.64 5.13 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.24 127.13 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.251 -1.53 . . . . 0.0 107.326 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.2 tt -104.65 135.12 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 111.687 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -113.65 129.51 56.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.937 -0.477 . . . . 0.0 110.308 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -109.09 102.68 11.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.8 m -103.39 99.19 9.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.6 mtt -91.43 102.08 14.76 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.201 1.001 . . . . 0.0 110.022 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.9 p -94.54 110.62 22.41 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.345 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.8 tp -112.52 78.62 1.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.66 -95.97 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.881 -0.512 . . . . 0.0 114.115 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.7 -26.72 17.65 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.9 mm -79.11 123.04 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 O-C-N 120.819 -1.175 . . . . 0.0 110.025 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.81 88.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -78.01 101.99 7.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.566 -1.334 . . . . 0.0 110.601 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -112.84 112.71 24.38 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -88.54 152.74 21.66 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.568 0.699 . . . . 0.0 110.207 168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.31 107.69 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -124.55 135.09 52.88 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.682 0.793 . . . . 0.0 111.693 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -95.49 136.97 35.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.548 -1.345 . . . . 0.0 113.342 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.56 122.73 16.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.574 1.88 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.249 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_